(Q43992366)

28 November 2017

title

Results of renal transplantation with different immunosuppressive regimens (English)

1 reference

28 November 2017

Inese Folkmane

1

1 reference

28 November 2017

J Bicans

2

1 reference

28 November 2017

S Chapenko

3

1 reference

28 November 2017

M Murovska

4

1 reference

28 November 2017

R Rosentals

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Transplantation Proceedings

28 November 2017

published in

1 reference

28 November 2017

volume

34

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

558-559

1 reference

Mycophenolate-update after it has come of age

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902845-7

7 January 2021

10.1016/S0041-1345(01)02845-7

Identifiers

DOI

1 reference

release_u2llpsiygnbw5ny6xzj4qv5aai

28 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u2llpsiygnbw5ny6xzj4qv5aai

24 November 2022

mapped directly with Wikidata item

1 reference